{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:40:09Z","timestamp":1750358409088,"version":"3.41.0"},"reference-count":156,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Cardiac resynchronization therapy (CRT) was shown to improve cardiac function, reduce heart failure hospitalizations, improve quality of life and prolong survival in patients with severe left ventricular dysfunction and intraventricular conduction disturbances, mainly left bundle branch block, on optimal medical therapy with ACE-inhibitors, \u03b2-blockers and mineralocorticoid receptor antagonists up-titrated to maximum tolerated evidence-based doses. CRT can be achieved by means of pacemaker systems (CRT-P) or devices with defibrillation capabilities (CRT-D). CRT-Ds offer an undoubted advantage in the prevention of arrhythmic death, but such an advantage may be of lesser degree in nonischemic heart failure etiologies. Moreover, the higher CRT-D hardware complexity compared to CRT-P may predispose to device\/lead malfunctions and the higher current drainage may cause a shorter battery duration with consequent premature replacements and the well-known incremental complications. In a period of financial constraints, also device costs should be carefully evaluated, with recent reports suggesting that CRT-Ps may be favored over CRT-Ds in patients with nonischemic cardiomyopathy and no prior history of cardiac arrhythmias from a cost-effectiveness point of view. The choice between a CRT-P or a CRT-D device should be patient-tailored whenever straightforward defibrillator indications are not present. The Goldenberg score may facilitate this decision-making process in ambiguous settings. Age, comorbidities, kidney disease, atrial fibrillation, advanced functional class, inappropriate therapy risk, implantable device infections, and malfunctions are factors potentially reducing the expected benefit from defibrillating capabilities. In the future, prospective randomized controlled trials are warranted to directly compare the efficacy and safety of CRT-Ps and CRT-Ds.<\/jats:p>","DOI":"10.1097\/crd.0000000000000388","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:54:14Z","timestamp":1616547254000},"page":"221-233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Resynchronization Therapy With or Without Defibrillation: A Long-Standing Debate"],"prefix":"10.1097","volume":"30","author":[{"given":"Pier Giorgio","family":"Golzio","sequence":"first","affiliation":[{"name":"From the Division of Cardiology, Department of Medical Sciences, University of Turin, \u201cCitt\u00e0 della Salute e della Scienza\u201d Hospital, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Paolo","family":"Bocchino","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Department of Medical Sciences, University of Turin, \u201cCitt\u00e0 della Salute e della Scienza\u201d Hospital, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Bissolino","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Department of Medical Sciences, University of Turin, \u201cCitt\u00e0 della Salute e della Scienza\u201d Hospital, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Angelini","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Department of Medical Sciences, University of Turin, \u201cCitt\u00e0 della Salute e della Scienza\u201d Hospital, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Gravinese","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Department of Medical Sciences, University of Turin, \u201cCitt\u00e0 della Salute e della Scienza\u201d Hospital, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Frea","sequence":"additional","affiliation":[{"name":"From the Division of Cardiology, Department of Medical Sciences, University of Turin, \u201cCitt\u00e0 della Salute e della Scienza\u201d Hospital, Turin, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"R2-20250619","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure.","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1540-8167.2008.01234.x","article-title":"Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors.","volume":"19","author":"Bai","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/europace\/eut032","article-title":"Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.","volume":"15","author":"Morani","year":"2013","journal-title":"Europace"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure.","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","article-title":"Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.","volume":"42","author":"Higgins","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa0706695","article-title":"Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.","volume":"357","author":"Beshai","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R14-20250619","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.108.818724","article-title":"Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I\/II heart failure.","volume":"120","author":"St John Sutton","year":"2009","journal-title":"Circulation"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events.","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure.","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bmj.39343.511389.BE","article-title":"Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.","volume":"335","author":"Lam","year":"2007","journal-title":"BMJ"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.","volume":"344","author":"Cazeau","year":"2001","journal-title":"N Engl J Med"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","article-title":"Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.","volume":"110","author":"Abraham","year":"2004","journal-title":"Circulation"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT.","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).","volume":"105","author":"B\u00e4nsch","year":"2002","journal-title":"Circulation"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2015-307634","article-title":"Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.","volume":"101","author":"Woods","year":"2015","journal-title":"Heart"},{"key":"R26-20250619","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"R27-20250619","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"key":"R28-20250619","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/eurheartj\/ehz773","article-title":"Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review.","volume":"41","author":"Barra","year":"2020","journal-title":"Eur Heart J"},{"key":"R29-20250619","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/eurheartj\/ehv455","article-title":"Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.","volume":"36","author":"Marijon","year":"2015","journal-title":"Eur Heart J"},{"key":"R30-20250619","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2017.04.021","article-title":"Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy: the GAUDI-CRT study.","volume":"11","author":"Acosta","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"R31-20250619","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.amjcard.2006.07.087","article-title":"Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.","volume":"99","author":"Auricchio","year":"2007","journal-title":"Am J Cardiol"},{"key":"R32-20250619","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/europace\/euv352","article-title":"Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.","volume":"18","author":"Barra","year":"2016","journal-title":"Europace"},{"key":"R33-20250619","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2017.06.056","article-title":"Impact of an age-adjusted co-morbidity index on survival of patients with heart failure implanted with cardiac resynchronization therapy devices.","volume":"120","author":"Ioannou","year":"2017","journal-title":"Am J Cardiol"},{"key":"R34-20250619","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/europace\/eus340","article-title":"Mortality and morbidity in cardiac resynchronization patients: impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome.","volume":"15","author":"Jastrzebski","year":"2013","journal-title":"Europace"},{"key":"R35-20250619","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/hrt.2007.129429","article-title":"Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation.","volume":"94","author":"Khadjooi","year":"2008","journal-title":"Heart"},{"key":"R36-20250619","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1053\/euhj.2002.3232","article-title":"Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation.","volume":"23","author":"Leclercq","year":"2002","journal-title":"Eur Heart J"},{"key":"R37-20250619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.117.007026","article-title":"Cardiac resynchronization therapy using quadripolar versus non-quadripolar left ventricular leads programmed to biventricular pacing with single-site left ventricular pacing: impact on survival and heart failure hospitalization.","volume":"6","author":"Leyva","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R38-20250619","first-page":"1977","article-title":"Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.","volume":"103","author":"Martens","year":"2017","journal-title":"Heart"},{"key":"R39-20250619","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cjca.2010.12.066","article-title":"Left ventricular lead position and nonspecific conduction delay are predictors of mortality in patients during cardiac resynchronization therapy.","volume":"27","author":"Prochnau","year":"2011","journal-title":"Can J Cardiol"},{"key":"R40-20250619","doi-asserted-by":"crossref","first-page":"e002756","DOI":"10.1161\/JAHA.115.002756","article-title":"Primary prevention implantable cardioverter defibrillator (ICD) therapy in women\u2014data from a multicenter French registry.","volume":"5","author":"Provid\u00eancia","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R41-20250619","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/pace.12631","article-title":"Long-term results of cardiac resynchronization therapy: a comparison between CRT-pacemakers versus primary prophylactic CRT-defibrillators.","volume":"38","author":"Reitan","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"R42-20250619","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF03086207","article-title":"Cardiac resynchronisation therapy: results from daily practice in Rijnstate Hospital, Arnhem.","volume":"17","author":"Rolink","year":"2009","journal-title":"Neth Heart J"},{"key":"R43-20250619","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCEP.115.003004","article-title":"Left ventricular lead electrical delay is a predictor of mortality in patients with cardiac resynchronization therapy.","volume":"8","author":"Roubicek","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R44-20250619","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.amjcard.2009.08.659","article-title":"Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.","volume":"105","author":"Soliman","year":"2010","journal-title":"Am J Cardiol"},{"key":"R45-20250619","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/clc.20683","article-title":"Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.","volume":"33","author":"Suzuki","year":"2010","journal-title":"Clin Cardiol"},{"key":"R46-20250619","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.hrthm.2012.04.021","article-title":"The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice.","volume":"9","author":"Thijssen","year":"2012","journal-title":"Heart Rhythm"},{"key":"R47-20250619","first-page":"1099","article-title":"Predictors of mortality in cardiac resynchronization therapy. Which patients benefit less from the therapy?","volume":"1","author":"Tolosana","year":"2011","journal-title":"Europace"},{"key":"R48-20250619","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/europace\/euv054","article-title":"Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.","volume":"18","author":"Trucco","year":"2016","journal-title":"Europace"},{"key":"R49-20250619","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehq252","article-title":"Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.","volume":"31","author":"van Bommel","year":"2010","journal-title":"Eur Heart J"},{"key":"R50-20250619","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/eurjhf\/hfs151","article-title":"Response to cardiac resynchronization therapy in elderly patients (\u226570 years) and octogenarians.","volume":"15","author":"Verbrugge","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"R51-20250619","first-page":"0009","article-title":"The long-term effects of single- or dual-chamber pacemakers upgraded biventricular pacing in patients with heart failure.","volume":"1","author":"Wang","year":"2010","journal-title":"Circulation"},{"key":"R52-20250619","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/CIRCULATIONAHA.105.538272","article-title":"Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.","volume":"112","author":"Yu","year":"2005","journal-title":"Circulation"},{"key":"R53-20250619","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.08.016","article-title":"Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.","volume":"44","author":"Bax","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R54-20250619","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ahj.2010.03.008","article-title":"A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.","volume":"159","author":"Boriani","year":"2010","journal-title":"Am Heart J"},{"key":"R55-20250619","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehp071","article-title":"Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study.","volume":"30","author":"Boveda","year":"2009","journal-title":"Eur Heart J"},{"key":"R56-20250619","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","article-title":"Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.","volume":"46","author":"Carson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R57-20250619","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1540-8167.2005.50062.x","article-title":"Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).","volume":"16","author":"Doshi","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R58-20250619","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2008.07.043","article-title":"Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.","volume":"52","author":"Di Biase","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R59-20250619","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/europace\/eun135","article-title":"Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.","volume":"10","author":"Ferreira","year":"2008","journal-title":"Europace"},{"key":"R60-20250619","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2013.12.005","article-title":"Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience.","volume":"172","author":"Frigerio","year":"2014","journal-title":"Int J Cardiol"},{"key":"R61-20250619","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/CIRCEP.113.000570","article-title":"Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (reverse).","volume":"6","author":"Gold","year":"2013","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"R62-20250619","first-page":"S23","article-title":"Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: the RD-CHF study.","volume":"30 Suppl 1","author":"Leclercq","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"R63-20250619","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/europace\/euv287","article-title":"The clinical outcome of cardiac resynchronization therapy in post-surgical valvular cardiomyopathy.","volume":"18","author":"Leyva","year":"2016","journal-title":"Europace"},{"key":"R64-20250619","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0735-1097(02)80545-9","article-title":"Reverse mechanical remodeling by biventricular pacing in congestive heart failure: one-year results from patients in atrial fibrillation in the MUSTIC (MUltisite STimulation in Cardiomyopathy) study.","volume":"39","author":"Linde","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R65-20250619","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jtcvs.2004.04.036","article-title":"Inverse T incision provides improved accessibility to the upper mediastinum.","volume":"129","author":"Marta","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R66-20250619","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.amjcard.2004.08.028","article-title":"Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.","volume":"94","author":"Molhoek","year":"2004","journal-title":"Am J Cardiol"},{"key":"R67-20250619","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/europace\/euv347","article-title":"Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.","volume":"18","author":"Palmisano","year":"2016","journal-title":"Europace"},{"key":"R68-20250619","doi-asserted-by":"crossref","first-page":"74F","DOI":"10.1016\/S0002-9149(02)03341-6","article-title":"Combining electrical therapies for advanced heart failure: the Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death.","volume":"91","author":"Pappone","year":"2003","journal-title":"Am J Cardiol"},{"key":"R69-20250619","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/eus247","article-title":"Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.","volume":"15","author":"Schuchert","year":"2013","journal-title":"Europace"},{"key":"R71-20250619","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/europace\/euq328","article-title":"The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality.","volume":"13","author":"Theuns","year":"2011","journal-title":"Europace"},{"key":"R72-20250619","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jacc.2008.10.032","article-title":"Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.","volume":"53","author":"Ypenburg","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R73-20250619","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2459\/JCM.0b013e3283638148","article-title":"Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.","volume":"15","author":"Bortnik","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R77-20250619","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure.","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"R78-20250619","doi-asserted-by":"crossref","first-page":"e016352","DOI":"10.1136\/bmjopen-2017-016352","article-title":"Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.","volume":"7","author":"Barakat","year":"2017","journal-title":"BMJ Open"},{"key":"R79-20250619","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10840-017-0260-8","article-title":"Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.","volume":"49","author":"Romero","year":"2017","journal-title":"J Interv Card Electrophysiol"},{"key":"R80-20250619","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/heartjnl-2017-311430","article-title":"Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis.","volume":"104","author":"Alba","year":"2018","journal-title":"Heart"},{"key":"R81-20250619","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/heartjnl-2016-310850","article-title":"Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.","volume":"104","author":"Beggs","year":"2018","journal-title":"Heart"},{"key":"R82-20250619","first-page":"CD012738","article-title":"Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.","volume":"12","author":"El Moheb","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R83-20250619","doi-asserted-by":"crossref","first-page":"f211","DOI":"10.1093\/europace\/eux324","article-title":"Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials.","volume":"20","author":"Romero","year":"2018","journal-title":"Europace"},{"key":"R84-20250619","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10741-018-9671-6","article-title":"Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.","volume":"23","author":"Siddiqui","year":"2018","journal-title":"Heart Fail Rev"},{"key":"R85-20250619","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/heartjnl-2018-313767","article-title":"Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy.","volume":"105","author":"Brown","year":"2019","journal-title":"Heart"},{"key":"R86-20250619","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14779072.2017.1307735","article-title":"Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.","volume":"15","author":"Manolis","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R87-20250619","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ejhf.185","article-title":"Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.","volume":"16","author":"Kutyifa","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"R88-20250619","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/europace\/euv212","article-title":"Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.","volume":"18","author":"Witt","year":"2016","journal-title":"Europace"},{"key":"R89-20250619","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.hrthm.2019.04.028","article-title":"Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: the United States experience from 2007 to 2014.","volume":"16","author":"Saba","year":"2019","journal-title":"Heart Rhythm"},{"key":"R90-20250619","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure.","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med"},{"key":"R91-20250619","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.joa.2017.03.002","article-title":"Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy.","volume":"33","author":"Yokoshiki","year":"2017","journal-title":"J Arrhythm"},{"key":"R92-20250619","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jce.12951","article-title":"Clinical characteristics and outcomes of older cardiac resynchronization therapy recipients using a pacemaker versus a defibrillator.","volume":"27","author":"Munir","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R93-20250619","first-page":"1357","article-title":"Morbidity and mortality with cardiac resynchronization therapy with pacing vs. with defibrillation in octogenarian patients in a real-world setting.","volume":"19","author":"Laish-Farkash","year":"2017","journal-title":"Europace"},{"key":"R94-20250619","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2018.03.087","article-title":"Cardiac resynchronization therapy in the ageing population - with or without an implantable defibrillator?","volume":"263","author":"D\u00f6ring","year":"2018","journal-title":"Int J Cardiol"},{"key":"R95-20250619","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/joa3.12377","article-title":"Trends in the use of implantable cardioverter-defibrillator and cardiac resynchronization therapy device in advancing age: analysis of the Japan cardiac device treatment registry database.","volume":"36","author":"Yokoshiki","year":"2020","journal-title":"J Arrhythm"},{"key":"R96-20250619","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacc.2007.08.058","article-title":"Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R97-20250619","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2012.02.036","article-title":"Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.","volume":"59","author":"Barsheshet","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R98-20250619","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1540-8167.2012.02413.x","article-title":"Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial.","volume":"24","author":"Noyes","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R99-20250619","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/eurheartj\/ehq408","article-title":"Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (resynchronization reverses remodeling in systolic left ventricular dysfunction).","volume":"32","author":"Linde","year":"2011","journal-title":"Eur Heart J"},{"key":"R100-20250619","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","article-title":"Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).","volume":"114","author":"Mark","year":"2006","journal-title":"Circulation"},{"key":"R101-20250619","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-142-8-200504190-00007","article-title":"Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.","volume":"142","author":"Al-Khatib","year":"2005","journal-title":"Ann Intern Med"},{"key":"R102-20250619","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/eurheartj\/ehi662","article-title":"Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.","volume":"26","author":"Calvert","year":"2005","journal-title":"Eur Heart J"},{"key":"R103-20250619","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.jacc.2005.08.033","article-title":"Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.","volume":"46","author":"Feldman","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R104-20250619","doi-asserted-by":"crossref","DOI":"10.3310\/hta11470","article-title":"The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.","volume":"11","author":"Fox","year":"2007","journal-title":"Health Technol Assess"},{"key":"R105-20250619","doi-asserted-by":"crossref","DOI":"10.3310\/hta10270","article-title":"A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.","volume":"10","author":"Buxton","year":"2006","journal-title":"Health Technol Assess"},{"key":"R106-20250619","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1136\/heartjnl-2015-308883","article-title":"Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure.","volume":"102","author":"Mealing","year":"2016","journal-title":"Heart"},{"issue":"suppl 2","key":"R107-20250619","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1093\/europace\/eur079","article-title":"Cardiac resynchronization therapy: a cost or an investment?","volume":"13","author":"Boriani","year":"2011","journal-title":"Europace"},{"key":"R109-20250619","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/13696998.2020.1746316","article-title":"Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data.","volume":"23","author":"Shah","year":"2020","journal-title":"J Med Econ"},{"key":"R110-20250619","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jacc.2014.06.1178","article-title":"20 years of cardiac resynchronization therapy.","volume":"64","author":"Leyva","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R111-20250619","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jce.12265","article-title":"Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.","volume":"25","author":"Richardson","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R112-20250619","first-page":"369","article-title":"Resincronizzazione cardiaca: morte, riospedalizzazione e complicanze correlate all\u2019impianto. Studio osservazionale triennale in un singolo centro del Sistema Sanitario Nazionale [Cardiac resynchronization therapy: mortality, rehospitalization, and procedure-related complications. A three-year single-center observational study within the Italian Health System].","volume":"13","author":"Palmieri","year":"2012","journal-title":"G Ital Cardiol (Rome)"},{"key":"R113-20250619","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/europace\/eum080","article-title":"Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety.","volume":"9","author":"Gras","year":"2007","journal-title":"Europace"},{"key":"R114-20250619","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.amjcard.2013.11.040","article-title":"Comparison of endovascular versus epicardial lead placement for resynchronization therapy.","volume":"113","author":"Garikipati","year":"2014","journal-title":"Am J Cardiol"},{"key":"R115-20250619","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1540-8159.2004.00438.x","article-title":"Sequential biventricular pacing: evaluation of safety and efficacy.","volume":"27","author":"Mortensen","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"R116-20250619","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/pace.12390","article-title":"Implantable defibrillators with enhanced detection algorithms: detection performance and safety results from the PainFree SST study.","volume":"37","author":"Wollmann","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"R117-20250619","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.112.000417","article-title":"Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.","volume":"129","author":"Gillis","year":"2014","journal-title":"Circulation"},{"key":"R118-20250619","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7326\/M13-1879","article-title":"Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.","volume":"160","author":"Masoudi","year":"2014","journal-title":"Ann Intern Med"},{"key":"R119-20250619","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1540-8159.2011.03082.x","article-title":"Safety and effectiveness of primary prevention cardioverter defibrillators in octogenarians.","volume":"34","author":"Strimel","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"R120-20250619","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2011.06.007","article-title":"Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials.","volume":"58","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R121-20250619","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.1235","article-title":"Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II.","volume":"20","author":"Linde","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R122-20250619","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/europace\/euz002","article-title":"Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?-findings from the ESC CRT Survey II.","volume":"21","author":"Normand","year":"2019","journal-title":"Europace"},{"key":"R123-20250619","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jacep.2019.06.003","article-title":"Sex-related procedural aspects and complications in CRT survey II: a multicenter European experience in 11,088 patients.","volume":"5","author":"Auricchio","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"R124-20250619","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"},{"key":"R125-20250619","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/europace\/euv296","article-title":"Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.","volume":"18","author":"von Gunten","year":"2016","journal-title":"Europace"},{"key":"R126-20250619","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/europace\/euv436","article-title":"Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.","volume":"18","author":"Boriani","year":"2016","journal-title":"Europace"},{"key":"R127-20250619","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.115.018830","article-title":"National trends in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.","volume":"133","author":"Lindvall","year":"2016","journal-title":"Circulation"},{"key":"R128-20250619","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/ejhf.1142","article-title":"CRT survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?","volume":"20","author":"Dickstein","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R129-20250619","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1540-8159.2009.02482.x","article-title":"Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection.","volume":"32","author":"Knops","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"R130-20250619","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/europace\/eun240","article-title":"Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.","volume":"10","author":"Biffi","year":"2008","journal-title":"Europace"},{"key":"R131-20250619","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2005.02.077","article-title":"The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators.","volume":"45","author":"Hauser","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R135-20250619","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.hrthm.2018.07.029","article-title":"Predicted longevity of contemporary cardiac implantable electronic devices: a call for industry-wide \u201cstandardized\u201d reporting.","volume":"15","author":"Munawar","year":"2018","journal-title":"Heart Rhythm"},{"key":"R136-20250619","doi-asserted-by":"crossref","first-page":"e012759","DOI":"10.1161\/JAHA.119.012759","article-title":"Favorable trend of implantable cardioverter-defibrillator service life in a large single-nation population: insights from 10-year analysis of the Italian implantable cardioverter-defibrillator registry.","volume":"8","author":"Poli","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R137-20250619","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ipej.2016.12.004","article-title":"Perspectives in managing recalls of cardiac implantable electronic devices.","volume":"16","author":"Varma","year":"2016","journal-title":"Indian Pacing Electrophysiol J"},{"key":"R138-20250619","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1540-8159.2012.03366.x","article-title":"Lessons from ICD lead recalls: what have we learned?","volume":"35","author":"Hauser","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"R139-20250619","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.hrthm.2006.02.011","article-title":"Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators.","volume":"3","author":"Hauser","year":"2006","journal-title":"Heart Rhythm"},{"key":"R140-20250619","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2007.12.070","article-title":"Complications of replacing implantable devices in response to advisories: a single center experience.","volume":"134","author":"Moore","year":"2009","journal-title":"Int J Cardiol"},{"key":"R141-20250619","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.hrthm.2008.09.020","article-title":"Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up.","volume":"5","author":"Gould","year":"2008","journal-title":"Heart Rhythm"},{"key":"R142-20250619","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jce.14087","article-title":"Long-term performance and lead failure analysis of the Durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead.","volume":"30","author":"Kleemann","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R143-20250619","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ipej.2018.12.001","article-title":"Rate and predictors of electrical failure in non-recalled defibrillator leads.","volume":"19","author":"Khattak","year":"2019","journal-title":"Indian Pacing Electrophysiol J"},{"key":"R144-20250619","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jacc.2015.12.067","article-title":"Implantable Cardiac Defibrillator Lead Failure and Management.","volume":"67","author":"Swerdlow","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R145-20250619","first-page":"E198","article-title":"The number of recalled leads is highly predictive of lead failure: results from the pacemaker and implantable defibrillator leads survival study (\u201cPAIDLESS\u201d).","volume":"28","author":"Kersten","year":"2016","journal-title":"J Invasive Cardiol"},{"key":"R146-20250619","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.amjcard.2014.10.025","article-title":"Failure rates of single- versus dual-coil nonrecalled sprint quattro defibrillator leads.","volume":"115","author":"Shariff","year":"2015","journal-title":"Am J Cardiol"},{"key":"R147-20250619","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/pace.12578","article-title":"Very late follow-up of a passive defibrillator lead under recall: do failure rates increase during long-term observation.","volume":"38","author":"Frey","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"R148-20250619","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.hrthm.2014.12.013","article-title":"Transvenous extraction profile of riata leads: procedural outcomes and technical complexity of mechanical removal.","volume":"12","author":"Bongiorni","year":"2015","journal-title":"Heart Rhythm"},{"key":"R149-20250619","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00399-013-0278-2","article-title":"[Lead survival and complications (except infections). Are we doing better nowadays?].","volume":"24","author":"Seifert","year":"2013","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"R150-20250619","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.hrthm.2013.07.001","article-title":"Early fatigue fractures in the IS-1 connector leg of a small-diameter ICD lead: value of returned product analysis for improving device safety.","volume":"10","author":"Hauser","year":"2013","journal-title":"Heart Rhythm"},{"key":"R151-20250619","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.hrthm.2013.06.021","article-title":"Transvenous extraction of implantable cardioverter-defibrillator leads under advisory\u2013a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.","volume":"10","author":"Brunner","year":"2013","journal-title":"Heart Rhythm"},{"key":"R152-20250619","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.hrthm.2013.09.067","article-title":"A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model.","volume":"10","author":"Bashir","year":"2013","journal-title":"Heart Rhythm"},{"key":"R153-20250619","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1540-8167.2012.02351.x","article-title":"Do ICD lead recalls affect physician\u2013or patient\u2013behavior? If not, why not?","volume":"23","author":"Lewis","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R154-20250619","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1161\/CIRCULATIONAHA.109.924357","article-title":"Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee.","volume":"121","author":"Parkash","year":"2010","journal-title":"Circulation"},{"key":"R155-20250619","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMp0800495","article-title":"Semper fidelis\u2013consumer protection for patients with implanted medical devices.","volume":"358","author":"Maisel","year":"2008","journal-title":"N Engl J Med"},{"key":"R156-20250619","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"key":"R157-20250619","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"R158-20250619","first-page":"1708","article-title":"Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.","volume":"17","author":"Unsworth","year":"2015","journal-title":"Europace"},{"key":"R159-20250619","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1540-8159.2011.03257.x","article-title":"Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.","volume":"35","author":"Uslan","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"R160-20250619","first-page":"1013","article-title":"Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications.","volume":"33","author":"Borleffs","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"key":"R161-20250619","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ahj.2017.03.009","article-title":"Effects of implantable cardioverter\/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy.","volume":"189","author":"Perini","year":"2017","journal-title":"Am Heart J"},{"key":"R162-20250619","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.hrthm.2017.12.026","article-title":"Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial.","volume":"15","author":"Sears","year":"2018","journal-title":"Heart Rhythm"},{"key":"R163-20250619","first-page":"1","article-title":"Remote monitoring of implantable cardioverter-defibrillators, cardiac resynchronization therapy and permanent pacemakers: a health technology assessment.","volume":"18","year":"2018","journal-title":"Ont Health Technol Assess Ser"},{"key":"R164-20250619","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/HCO.0000000000000471","article-title":"Remote monitoring of implantable cardiac devices: current state and future directions.","volume":"33","author":"Ganeshan","year":"2018","journal-title":"Curr Opin Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:01:06Z","timestamp":1750356066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000388","relation":{},"ISSN":["1061-5377"],"issn-type":[{"type":"print","value":"1061-5377"}],"subject":[],"published":{"date-parts":[[2021,3,19]]}}}